Collectively, these findings provide pharmacological evidence that Emodin targeted BCL‐10 regulates the BCL‐10/MALT1 complex and suppresses NF‐κB activation, ultimately conferring significant multiorgan protective effects in sepsis. This evidence concerns the gene MALT1 and Sepsis.